A kinase-independent role for CDK8 in BCR-ABL1+ leukemia
Cyclin-dependent kinases are deregulated in blood cancers. Here, the authors show that CDK8, independent of its kinase activity, regulates mTOR signalling for the maintenance of BCR-ABL1+ leukemia, and that the dual inhibition of CDK8 and mTOR signalling induces apoptosis in these cells.
Enregistré dans:
Auteurs principaux: | Ingeborg Menzl, Tinghu Zhang, Angelika Berger-Becvar, Reinhard Grausenburger, Gerwin Heller, Michaela Prchal-Murphy, Leo Edlinger, Vanessa M. Knab, Iris Z. Uras, Eva Grundschober, Karin Bauer, Mareike Roth, Anna Skucha, Yao Liu, John M. Hatcher, Yanke Liang, Nicholas P. Kwiatkowski, Daniela Fux, Andrea Hoelbl-Kovacic, Stefan Kubicek, Junia V. Melo, Peter Valent, Thomas Weichhart, Florian Grebien, Johannes Zuber, Nathanael S. Gray, Veronika Sexl |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/90ab601100a74a6da15edcbbea0a9c4e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Characteristics of BCR–ABL gene variants in patients of chronic myeloid leukemia
par: Amin Huma, et autres
Publié: (2021) -
Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
par: Diletta Fontana, et autres
Publié: (2021) -
Regulatory effects of sestrin 3 (SESN3) in BCR-ABL expressing cells.
par: Eliza Vakana, et autres
Publié: (2013) -
Galectin-9 binds IgM-BCR to regulate B cell signaling
par: Anh Cao, et autres
Publié: (2018) -
A Novel ELISA-Based Peptide Biosensor Assay for Screening ABL1 Activity in vitro: A Challenge for Precision Therapy in BCR-ABL1 and BCR-ABL1 Like Leukemias
par: Oksana Montecchini, et autres
Publié: (2021)